ZVRA Earnings — Zevra Therapeutics, Inc. Common Stock Post-ER Performance | BigEarnings
ZVRA — Zevra Therapeutics, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$12.77
Market Cap$754.9M
P/E6.7
52W Range$7.16 – $15.04
Next Earnings2026-08-11
About Zevra Therapeutics, Inc. Common Stock
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
